Parker W, Yu P B, Holzknecht Z E, Lundberg K, Buckley R H, Platt J L
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Clin Immunol. 1997 Jul;17(4):311-21. doi: 10.1023/a:1027378716015.
The origin of natural antibodies has long been a subject of controversy. Polyreactive natural antibodies recognize multiple ligands and are thought to arise from B1 B cells. Natural antibodies against carbohydrate antigens such as Gal alpha 1-3Gal or against blood groups A and B are thought to be "elicited" by gut bacteria, but their origin is uncertain. To explore the origin of naturally occurring anticarbohydrate antibodies, the specificity and function of the xenoreactive antibodies and isohemagglutinins were investigated in immunodeficient subjects. Subjects with defects in T cell-dependent antibody synthesis had normal levels of xenoreactive natural antibodies, most of which, like xenoreactive antibodies from normal individuals, were specific for Gal alpha 1-3Gal. On the other hand, some subjects with hyper-IgM syndrome who were able to synthesize abundant quantities of xenoreactive antibodies and polyreactive antibodies were devoid of anti-Gal alpha 1-3Gal antibodies. These results suggest that the lineages of B cells giving rise to anti-Gal alpha 1-3Gal antibodies and isohemagglutinins are distinct from B1 B cells or at least exist at a more "advanced" stage of development than those B1 B cells that give rise to polyreactive antibodies. The findings also suggest that B cells which synthesize anti-Gal alpha 1-3Gal antibodies and isohemagglutinins may be distinct from B2 B cells or exist at a more "primitive" stage of development than B2 B cells that synthesize elicited antibodies in normal individuals.
天然抗体的起源长期以来一直是一个有争议的话题。多反应性天然抗体可识别多种配体,被认为起源于B1 B细胞。针对碳水化合物抗原(如α1-3半乳糖)或血型A和B的天然抗体被认为是由肠道细菌“引发”的,但其起源尚不确定。为了探究天然存在的抗碳水化合物抗体的起源,研究了免疫缺陷受试者中异种反应性抗体和同种血凝素的特异性及功能。T细胞依赖性抗体合成存在缺陷的受试者,其异种反应性天然抗体水平正常,其中大多数,与正常个体的异种反应性抗体一样,对α1-3半乳糖具有特异性。另一方面,一些患有高IgM综合征且能够合成大量异种反应性抗体和多反应性抗体的受试者却缺乏抗α1-3半乳糖抗体。这些结果表明,产生抗α1-3半乳糖抗体和同种血凝素的B细胞谱系与B1 B细胞不同,或者至少比产生多反应性抗体的B1 B细胞处于更“高级”的发育阶段。这些发现还表明,合成抗α1-3半乳糖抗体和同种血凝素的B细胞可能与B2 B细胞不同,或者比在正常个体中合成引发性抗体的B2 B细胞处于更“原始”的发育阶段。